SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001358403-20-000024
Filing Date
2020-09-16
Accepted
2020-09-16 16:42:27
Documents
15
Period of Report
2020-09-10
Items
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K blcm-20200910.htm   iXBRL 8-K 52456
2 EX-14.1 exh141-blcmcodeofbusin.htm EX-14.1 95232
  Complete submission text file 0001358403-20-000024.txt   343393

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blcm-20200910.xsd EX-101.SCH 2423
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT blcm-20200910_cal.xml EX-101.CAL 710
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blcm-20200910_def.xml EX-101.DEF 15011
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blcm-20200910_lab.xml EX-101.LAB 28964
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blcm-20200910_pre.xml EX-101.PRE 15608
8 EXTRACTED XBRL INSTANCE DOCUMENT blcm-20200910_htm.xml XML 13489
Mailing Address 2710 REED ROAD SUITE 160 HOUSTON TX 77051
Business Address 2710 REED ROAD SUITE 160 HOUSTON TX 77051 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36783 | Film No.: 201179247
SIC: 2834 Pharmaceutical Preparations